IL6 and obesity disorder: In obesity and in type 2 diabetes, FAPs can cause chronic inflammation, fibrosis, intramuscular fat accumulation in skeletal muscle and muscle fiber degeneration by secreting pro-inflammatory cytokines as IL-6 [165,166,167].